Guidance updated on PSA testing for prostate cancer
We have published updated guidance for GPs and well men aged 50 and over about prostate specific antigen (PSA) testing for prostate cancer.
Janet Rimmer
Janet was appointed senior implementation lead for HPV in January 2017. She has worked in cancer screening as the coordinator for laboratories since 2001. She has a wealth of experience in the NHS Cervical Screening Programme, relating in particular to HPV testing, piloting and implementation. She also manages the NHS Prostate Cancer Risk Management Programme. Before joining the screening team her background was as a biomedical scientist working for the Sheffield Teaching Hospitals NHS Foundation Trust. In her spare time Janet enjoys running, gardening and spending time with her family.
HPV primary screening report published
Explanation to accompany a new cervical screening HPV primary report.
HPV primary cervical screening pilot report published in BMJ
In 2013, 6 labs in England began looking for HPV first to see if this new test could be used in the cervical screening programme. The results from this pilot have now been published in the British Medical Journal (BMJ).
New HPV implementation guidance for cervical screening providers
We have published new guidance for local cervical screening providers on implementing high-risk human papillomavirus (hrHPV) testing as the programme’s primary screening test.
Cervical screening failsafe updated
Over the last few months we've been working hard to update and improve the existing cervical screening failsafe guidelines and screening services need to be aware of the updated requirements.
New guidance for cervical screening provider leads
Posted by:
Janet Rimmer and Philippa Pearmain, Posted on:
-
Categories:
NHS Cervical Screening Programme
PHE has published guidance describing the role and responsibilities of cervical screening provider leads.
New guidance to help cervical screening providers reduce cytology backlogs
PHE Screening has published guidance for laboratories and local cervical screening providers to support the option of mitigating against the risk of longer cytology backlogs by using primary HPV screening pilot sites.
NHS Cervical Screening Programme approves new HPV tests and issues guidance for laboratories
Cervical screening saves an estimated 5,000 lives a year by detecting abnormalities of the cervix early and referring women for effective treatment.